The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 332:1787-1790 June 29, 1995 Number 26
NextNext

Staging of Head and Neck Cancer

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Brennan, J. A.
To the Editor: Brennan et al. (Feb. 16 issue)1 are to be commended for their important and well-executed study. This is an excellent example of the use of emerging molecular-biology techniques to address important clinical questions. The clinical usefulness of the study would have been augmented, however, if the authors had provided details of the radiotherapy administered.

Because radiation kills cells exponentially, its success is inversely related to the log of the clonogenic cells within the treated volume.2 The tumor-cell burden is higher in patients with positive margins, and it is for this reason that radiation decreases the rate of . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.